Literature DB >> 23213104

Understanding the role of MET kinase in cancer therapy.

Edwin M Posadas, Robert A Figlin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23213104     DOI: 10.1200/JCO.2012.46.7738

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer.

Authors:  Andreas Varkaris; Paul G Corn; Nila U Parikh; Eleni Efstathiou; Jian H Song; Yu-Chen Lee; Ana Aparicio; Anh G Hoang; Sanchaika Gaur; Lynnelle Thorpe; Sankar N Maity; Menashe Bar Eli; Bogdan A Czerniak; Yiping Shao; Mian Alauddin; Sue-Hwa Lin; Christopher J Logothetis; Gary E Gallick
Journal:  Clin Cancer Res       Date:  2015-08-13       Impact factor: 12.531

2.  Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features.

Authors:  Qiu-Yuan Xia; Qiu Rao; Qin Shen; Shan-Shan Shi; Li Li; Biao Liu; Jin Zhang; Yan-Fen Wang; Qun-Li Shi; Jian-Dong Wang; Heng-Hui Ma; Zhen-Feng Lu; Bo Yu; Ru-Song Zhang; Xiao-Jun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

3.  Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.

Authors:  Craig W Menges; Yuwaraj Kadariya; Deborah Altomare; Jacqueline Talarchek; Erin Neumann-Domer; Yue Wu; Guang-Hui Xiao; Irina M Shapiro; Vihren N Kolev; Jonathan A Pachter; Andres J Klein-Szanto; Joseph R Testa
Journal:  Cancer Res       Date:  2013-12-26       Impact factor: 12.701

Review 4.  The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment.

Authors:  Rahul A Parikh; Peng Wang; Jan H Beumer; Edward Chu; Leonard J Appleman
Journal:  Onco Targets Ther       Date:  2014-06-11       Impact factor: 4.147

5.  Foretinib Enhances the Radiosensitivity in Esophageal Squamous Cell Carcinoma by Inhibiting Phosphorylation of c-Met.

Authors:  Guang-Zong Chen; Wang-Shu Dai; Hong-Cheng Zhu; Hong-Mei Song; Xi Yang; Yuan-Dong Wang; Hua Min; Qian Lu; Shu Liu; Xin-Chen Sun; Xiao-Ning Zeng
Journal:  J Cancer       Date:  2017-03-12       Impact factor: 4.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.